# Simplify Genetic Test Claim Complexities with Concert Genetics and Payment Accuracy Edge
## Key Facts
- **150K+ genetic tests available** are contributing to increased complexity in medical policy, coding, and utilization review for genetic tests. (Section: “Simplify Genetic Test Claim Complexities…”, stats callout)
- **6.9 codes per test (on average)** adds coding complexity that can drive more prior authorizations, denials, reviews, and appeals if not managed properly. (Section: “Simplify Genetic Test Claim Complexities…”, stats callout; intro paragraphs)
- **1K+ pages of policy to comprehend** is cited as part of the administrative burden associated with genetic testing policy and payment integrity workflows. (Section: “Simplify Genetic Test Claim Complexities…”, stats callout)
- **Concert Genetics offers nearly 40 active edits** that can be accessed from within the **Payment Accuracy Edge** interface as part of its third-party ecosystem. (Section: “How it Works”)
- **Clinical edits** can flag tests that “typically aren’t covered by health plans,” including **add-on procedures**, **primary and secondary LCDs**, **covered & non-covered diagnosis codes**, and **denied codes**. (Section: “How it Works”)
- **Coding edits** align to “the current procedure codes and the AMA’s coding guidelines,” including checks for **invalid procedure code**, **unbundled codes billed when panel code exists**, **too many units**, **procedure code restricted to specific laboratories for proprietary tests or algorithms**, and **missing or incomplete diagnosis code**. (Section: “How it Works”)
## Summary
### Why genetic test claims are getting harder to manage
Genetic testing—defined here as analyzing a person’s DNA to identify changes or mutations that may indicate risk for certain diseases or conditions—has expanded rapidly, creating added complexity for health plans. The content highlights **150K+ genetic tests available**, an average of **6.9 codes per test**, and **1K+ pages of policy to comprehend**, all of which can increase administrative burden across medical policy, coding, and utilization review. If genetic testing is not managed properly, health plans may face an overwhelming number of **prior authorizations, denials, reviews, and appeals**, which can clog payment integrity processes. (Intro paragraphs; stats callout; genetic testing definition)
### How Payment Accuracy Edge integrates Concert Genetics edits
To improve the accuracy and automation of genetic test edits, **Payment Accuracy Edge (formerly HealthEdge Source™)** partners with **Concert Genetics**. As part of the Payment Accuracy Edge third-party ecosystem, Concert Genetics edits are available directly within the Payment Accuracy Edge interface, with **nearly 40 active edits** described. These edits include both clinical and coding-focused checks intended to address coverage and coding challenges in genetic test claims. (Intro paragraphs; “How it Works”)
### What the edits cover and the types of claims included
The described **clinical edits** flag tests that typically aren’t covered by health plans (e.g., add-on procedures; primary and secondary LCDs; covered and non-covered diagnosis codes; denied codes). The **coding edits** are based on “the current procedure codes and the AMA’s coding guidelines,” and include validations and rules such as invalid procedure codes, unbundling when a panel code exists, excessive units billed, restrictions tied to proprietary tests or algorithms, and missing or incomplete diagnosis codes. Concert Genetics is also described as covering a wide range of claims, including **molecular pathology**, **genomic sequencing procedures and other molecular multianalyte**, **multianalyte assays with algorithmic analyses**, and **proprietary laboratory analyses (PLA) codes**. (Section: “How it Works”; “Wide Claim Coverage”)